BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 22, 2025
Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Modex, IsoTis Plan To Merge Programs In Orthopedics, Skin

Sep. 25, 2002
By Cormac Sheridan

Modex, IsoTis Plan To Merge Programs In Orthopedics, Skin

Sep. 24, 2002
By Cormac Sheridan

Modex, IsoTis Plan To Merge Programs In Orthopedics, Skin

Sep. 24, 2002
By Cormac Sheridan

Actelion Moving Tezosentan Into Phase III For Acute Heart Failure

Sep. 18, 2002
By Cormac Sheridan

Lund University Establishing Stem Cell Research Institute

Sep. 18, 2002
By Cormac Sheridan

GPCRs Focus Of Deals Involving Biovitrium, BioFocus, BioXell

Sep. 18, 2002
By Cormac Sheridan
G protein-coupled receptors, the superfamily of membrane-spanning proteins involved in diverse signaling processes, are the subject of two drug discovery collaborations unveiled last week by European biotechnology firms. (BioWorld International)
Read More

Lund University Establishing Stem Cell Research Institute

Sep. 18, 2002
By Cormac Sheridan

GPCRs Focus Of Deals Involving Biovitrium, BioFocus, BioXell

Sep. 18, 2002
By Cormac Sheridan
G protein-coupled receptors, the superfamily of membrane-spanning proteins involved in diverse signaling processes, are the subject of two drug discovery collaborations unveiled last week by European biotechnology firms. (BioWorld International)
Read More

Actelion Moving Tezosentan Into Phase III For Acute Heart Failure

Sep. 18, 2002
By Cormac Sheridan

Medivir To Lose CEO Frick To Venture Capital Fund

Sep. 11, 2002
By Cormac Sheridan
Previous 1 2 … 319 320 321 322 323 324 325 326 327 … 335 336 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 20, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 18, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 17, 2025
  • Red blood cells in an artery with cholesterol

    In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol

    BioWorld
    In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
  • Enflonsia

    Merck wins FDA approval in pediatric RSV and steps into CDC uncertainty

    BioWorld
    With the U.S. FDA’s approval of Enflonsia (clesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing